PROSIGNA ASSAY
Total Payments
$2.0M
Transactions
881
Doctors
216
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $622,540 | 67 | 15 |
| 2018 | $544,625 | 578 | 121 |
| 2017 | $790,689 | 236 | 127 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.5M | 69 | 77.6% |
| Unspecified | $252,628 | 4 | 12.9% |
| Honoraria | $108,638 | 43 | 5.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,722 | 6 | 1.8% |
| Food and Beverage | $21,731 | 733 | 1.1% |
| Consulting Fee | $13,154 | 13 | 0.7% |
| Travel and Lodging | $6,076 | 13 | 0.3% |
Payments by Type
General
$1.7M
877 transactions
Research
$252,628
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STRATEGIC ALLIANCE AGREEMENT | NanoString Technologies, Inc. | $252,628 | 0 |
Top Doctors Receiving Payments for PROSIGNA ASSAY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD PHD | Medical Oncology | Houston, TX | $678,451 | 20 |
| , M.D | Anatomic Pathology & Clinical Pathology | Salt Lake City, UT | $676,654 | 17 |
| Unknown | — | Charlotte, NC | $422,192 | 41 |
| , MD | Anatomic Pathology | Nashville, TN | $77,765 | 69 |
| , MD PHD | Clinical Genetics (M.D.) | Seattle, WA | $31,387 | 3 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Rochester, MN | $5,763 | 4 |
| , M.D | Hematology & Oncology | Houston, TX | $3,622 | 6 |
| , M.D., PHD | Medical Oncology | New York, NY | $3,332 | 4 |
| , MD PHD | Internal Medicine | Philadelphia, PA | $2,981 | 4 |
| , MD | Specialist | Orange, CA | $2,718 | 4 |
| , MD | Hematology | Memphis, TN | $2,632 | 3 |
| , MD | Internal Medicine | Boston, MA | $2,630 | 3 |
| , M.D | Medical Oncology | Baltimore, MD | $2,629 | 3 |
| , MD | Medical Oncology | New Haven, CT | $2,629 | 3 |
| , M.D | Medical Oncology | New York, NY | $2,626 | 3 |
| , M.D | Hematology & Oncology | Jacksonville, FL | $2,602 | 2 |
| , M.D | Internal Medicine | Tucson, AZ | $2,602 | 2 |
| , M.D | Specialist | Philadelphia, PA | $2,602 | 2 |
| , MD | Hematology & Oncology | East Brunswick, NJ | $2,602 | 2 |
| , MD | Medical Oncology | Columbus, OH | $2,602 | 2 |
| Claudine Isaacs | Hematology & Oncology | Washington Dc, DC | $2,602 | 2 |
| , M.D | Hematology & Oncology | Minneapolis, MN | $2,500 | 1 |
| , MD | Medical Oncology | Cape Coral, FL | $1,925 | 22 |
| , M.D | Medical Oncology | Murfreesboro, TN | $1,079 | 2 |
| , MD | Medical Oncology | Gallatin, TN | $1,065 | 2 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $2.0M
- Total Doctors 216
- Transactions 881
About PROSIGNA ASSAY
PROSIGNA ASSAY is a device associated with $2.0M in payments to 216 healthcare providers, recorded across 881 transactions in the CMS Open Payments database. The primary manufacturer is NanoString Technologies, Inc..
Payment data is available from 2017 to 2019. In 2019, $622,540 was paid across 67 transactions to 15 doctors.
The most common payment nature for PROSIGNA ASSAY is "Royalty or License" ($1.5M, 77.6% of total).
PROSIGNA ASSAY is associated with 1 research study, including "STRATEGIC ALLIANCE AGREEMENT" ($252,628).